APA (7th ed.) Citation

JW, O., FR, M. C., BL, C., AS, D., PS, J., CSP, L., . . . M, V. (2026). Finerenone Across the Spectrum of Kidney Risk in Heart Failure: The FINEARTS-HF Trial. JACC. Heart failure, 14(1), 102439. https://doi.org/10.1016/j.jchf.2025.03.006

Chicago Style (17th ed.) Citation

JW, Ostrominski, et al. "Finerenone Across the Spectrum of Kidney Risk in Heart Failure: The FINEARTS-HF Trial." JACC. Heart Failure 14, no. 1 (2026): 102439. https://doi.org/10.1016/j.jchf.2025.03.006.

MLA (9th ed.) Citation

JW, Ostrominski, et al. "Finerenone Across the Spectrum of Kidney Risk in Heart Failure: The FINEARTS-HF Trial." JACC. Heart Failure, vol. 14, no. 1, 2026, p. 102439, https://doi.org/10.1016/j.jchf.2025.03.006.